EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...
California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...
The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...
This is read by an automated voice. Please report any issues or inconsistencies here. Gov. Gavin Newsom said $11 insulin pens will soon be available through the state’s pharmaceutical label.
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. California Gov. Gavin Newsom announces CalRx ...
Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1. The insulin is from a state-branded form of the medicine, CalRx. Lawmakers ...
Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a Cedars-Sinai pharmacy in Los Angeles on Thursday. The effort is part of ...
California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a ...
California Gov. Gavin Newsom on Thursday announced a plan to offer $11 insulin pens through the state's pharmaceutical venture. Beginning Jan. 1, consumers can purchase a five-pack of pens for a ...
California Gov. Gavin Newsom announces CalRx-branded insulin glargine pens available next Jan. 1, 2026, at a suggested retail price of no more than $55 per five-pack, or $11 per pen, during a news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback